| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0058 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |